Works matching IS 11791535 AND DT 2017 AND VI 9
Results: 23
Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3449, doi. 10.2147/DDDT.S150187
- By:
- Publication type:
- Article
Anacetrapib as a potential cardioprotective strategy.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3497, doi. 10.2147/DDDT.S114104
- By:
- Publication type:
- Article
Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3441, doi. 10.2147/DDDT.S149913
- By:
- Publication type:
- Article
Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3579, doi. 10.2147/DDDT.S121298
- By:
- Publication type:
- Article
Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 27, doi. 10.2147/HMER.S129681
- By:
- Publication type:
- Article
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum].
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3589, doi. 10.2147/DDDT.S158965
- Publication type:
- Article
Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3471, doi. 10.2147/DDDT.S151420
- By:
- Publication type:
- Article
EUREKA study - the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3551, doi. 10.2147/DDDT.S142580
- By:
- Publication type:
- Article
Resveratrol as a potential therapeutic drug for respiratory system diseases.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3591, doi. 10.2147/DDDT.S148868
- By:
- Publication type:
- Article
Regulation profile of the intestinal peptide transporter 1 (PepT1).
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3511, doi. 10.2147/DDDT.S151725
- By:
- Publication type:
- Article
Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3503, doi. 10.2147/DDDT.S152366
- By:
- Publication type:
- Article
Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3543, doi. 10.2147/DDDT.S148534
- By:
- Publication type:
- Article
Decreasing racial disparity with the combination of ledipasvir-sofosbuvir for the treatment of chronic hepatitis C.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 13, doi. 10.2147/HMER.S118063
- By:
- Publication type:
- Article
Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3519, doi. 10.2147/DDDT.S151422
- By:
- Publication type:
- Article
Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3567, doi. 10.2147/DDDT.S152489
- By:
- Publication type:
- Article
Gut microbiota-derived short-chain fatty acids and kidney diseases.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3531, doi. 10.2147/DDDT.S150825
- By:
- Publication type:
- Article
Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 3559, doi. 10.2147/DDDT.S119545
- By:
- Publication type:
- Article
Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 45, doi. 10.2147/HMER.S142600
- By:
- Publication type:
- Article
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 37, doi. 10.2147/hmer.s146438
- By:
- Publication type:
- Article
Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum].
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 35, doi. 10.2147/hmer.s143866
- Publication type:
- Article
Hepatitis C infection in Egypt: prevalence, impact and management strategies.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 17, doi. 10.2147/HMER.S113681
- By:
- Publication type:
- Article
Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 7, doi. 10.2147/HMER.S124274
- By:
- Publication type:
- Article
Unresectable hepatoblastoma: current perspectives.
- Published in:
- Hepatic Medicine: Evidence & Research, 2017, v. 9, p. 1, doi. 10.2147/HMER.S89997
- By:
- Publication type:
- Article